Review of Hydroxypropyl Methylcellulose in Artificial Tears for the Treatment of Dry eye disease.
DED
HPMC
artificial tears
dry eye disease
hydroxypropyl methylcellulose
hypromellose
Journal
Acta ophthalmologica
ISSN: 1755-3768
Titre abrégé: Acta Ophthalmol
Pays: England
ID NLM: 101468102
Informations de publication
Date de publication:
01 Sep 2024
01 Sep 2024
Historique:
received:
12
06
2024
accepted:
11
08
2024
medline:
2
9
2024
pubmed:
2
9
2024
entrez:
2
9
2024
Statut:
aheadofprint
Résumé
Dry eye disease (DED) is a highly prevalent condition, resulting in reduced quality of life, lower participation in social life and impaired work efficiency. Hydroxypropyl methylcellulose (HPMC) is a cellulose-based viscosity-enhancing agent and is one of the most popular therapeutic ingredients in artificial tears. This review aims to evaluate the literature on the efficacy and safety of HPMC used in the treatment of DED. Literature searches were conducted in PubMed and Cochrane CENTRAL. A total of 28 clinical trials from 26 publications are included in this review, including 21 clinical intervention studies evaluating the effect of HPMC treatment over time and seven single instillation studies evaluating the short-term physical and symptomatic effects of HPMC after drop-instillation. The duration of clinical intervention studies ranged from 2 weeks to 5.5 months. DED severity ranged from mild to severe. Drop frequency ranged from two to up to 16 drops per day. HPMC concentration in artificial tears ranged from 0.2% to 0.5%. No major complications or adverse events were reported. Artificial tears containing HPMC were effective at improving symptoms and some signs of DED. However, combination drops with HPMC plus other therapeutic ingredients seem more effective than HPMC alone. HPMC appears to be equally effective or inferior to hyaluronic acid (HA). There is no evidence of superiority or inferiority to either carboxymethylcellulose (CMC) or polyethylene glycol 400/propylene glycol (PEG/PG). No single study explained the choice of drop frequency or HPMC concentration. More well-designed studies are needed to determine an evidence-based standard for HPMC treatment, including drop frequency, concentration and molecular weight for different DED severity and subgroups.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Author(s). Acta Ophthalmologica published by John Wiley & Sons Ltd on behalf of Acta Ophthalmologica Scandinavica Foundation.
Références
Akkaya, S. (2018) The effect of artificial tear preparations with three different ingredients on contrast sensitivity in patients with dry eye syndrome. Med Hypothesis Discov Innov Ophthalmol, 7, 89–93.
Albietz, J.M., Lenton, L.M., McLennan, S.G. & Earl, M.L. (2002) A comparison of the effect of refresh plus and bion tears on dry eye symptoms and ocular surface health in myopic LASIK patients. The CLAO Journal, 28, 96–100.
Bartlett, J.D., Keith, M.S., Sudharshan, L. & Snedecor, S.J. (2015) Associations between signs and symptoms of dry eye disease: a systematic review. Clinical Ophthalmology, 9, 1719–1730.
Baudouin, C., Labbé, A., Liang, H., Pauly, A. & Brignole‐Baudouin, F. (2010) Preservatives in eyedrops: the good, the bad and the ugly. Progress in Retinal and Eye Research, 29, 312–334.
Boisjoly, H. & Charest, M. (2003) Comparison of GenTeal® gel and refresh Liquigel™ for persistent dry eye. Clinical and Surgical Ophthalmology, 21, 430–432.
Bron, A.J., de Paiva, C.S., Chauhan, S.K., Bonini, S., Gabison, E.E., Jain, S. et al. (2017) TFOS DEWS II pathophysiology report. The Ocular Surface, 15, 438–510.
Bron, A.J., Evans, V.E. & Smith, J.A. (2003) Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea, 22, 640–650.
Brzheskiy, V.V., Efimova, E.L., Vorontsova, T.N., Alekseev, V.N., Gusarevich, O.G., Shaidurova, K.N. et al. (2015) Results of a multicenter, randomized, double‐masked, placebo‐controlled clinical study of the efficacy and safety of Visomitin eye drops in patients with dry eye syndrome. Advances in Therapy, 32, 1263–1279.
Capita, L., Chalita, M.R. & dos Santos‐Neto, L.L. (2015) Prospective evaluation of Hypromellose 2% for punctal occlusion in patients with dry eye. Cornea, 34, 188–192.
Chen, D., Zhang, S., Bian, A., Hong, J., Deng, Y., Zhang, M. et al. (2019) Efficacy and safety of 0.05% cyclosporine ophthalmic emulsion in treatment of Chinese patients with moderate to severe dry eye disease: A 12‐week, multicenter, randomized, double‐masked, placebo‐controlled phase III clinical study. Medicine (Baltimore), 98, e16710.
Cher, I. (2008) A new look at lubrication of the ocular surface: fluid mechanics behind the blinking eyelids. The Ocular Surface, 6, 79–86.
Cömez, A.T., Tufan, H.A., Kocabıyık, O. & Gencer, B. (2013) Effects of lubricating agents with different osmolalities on tear osmolarity and other tear function tests in patients with dry eye. Current Eye Research, 38, 1095–1103.
Conrady, C.D., Joos, Z.P. & Patel, B.C. (2016) Review: the lacrimal gland and its role in dry eye. Journal of Ophthalmology, 2016, 7542929.
Craig, J.P., Nichols, K.K., Akpek, E.K., Caffery, B., Dua, H.S., Joo, C.‐K. et al. (2017) TFOS DEWS II definition and classification report. The Ocular Surface, 15, 276–283.
Dilly, P.N. (1994) Structure and function of the tear film. In: Sullivan, D.A. (Ed.) Lacrimal gland, tear film, and dry eye syndromes: basic science and clinical relevance. Boston, MA: Springer US, pp. 239–247.
Donshik, P.C., Nelson, J.D., Abelson, M., McCulley, J.P., Beasley, C. & Laibovitz, R.A. (1998) Effectiveness of BION tears, cellufresh, aquasite, and refresh plus for moderate to severe dry eye. Advances in Experimental Medicine and Biology, 438, 753–760.
Durrie, D.S. & Trattler, W. (2005) A comparison of therapeutic regimens containing moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% ophthalmic solution for surgical prophylaxis in patients undergoing LASIK or LASEK. Journal of Ocular Pharmacology and Therapeutics, 21, 236–241.
Galor, A., Batawi, H., Felix, E.R., Margolis, T.P., Sarantopoulos, K.D., Martin, E.R. et al. (2016) Incomplete response to artificial tears is associated with features of neuropathic ocular pain. The British Journal of Ophthalmology, 100, 745–749.
Garcia‐lázaro, S., Belda‐salmerón, L., Ferrer‐blasco, T., Cerviño, A. & Montés‐micó, R. (2011) Comparison of two artificial tear formulations for dry eye through high‐resolution optical coherence tomography. Clinical and Experimental Optometry, 94, 549–556.
Goldstein, M.H., Silva, F.Q., Blender, N., Tran, T. & Vantipalli, S. (2022) Ocular benzalkonium chloride exposure: problems and solutions. Eye (London, England), 36, 361–368.
Grene, R.B., Lankston, P., Mordaunt, J., Harrold, M., Gwon, A. & Jones, R. (1992) Unpreserved carboxymethylcellulose artificial tears evaluated in patients with keratoconjunctivitis sicca. Cornea, 11, 294–301.
Hynnekleiv, L., Magno, M., Moschowits, E., Tønseth, K.A., Vehof, J. & Utheim, T.P. (2023) A comparison between hyaluronic acid and other single ingredient eye drops for dry eye, a review. Acta Ophthalmologica, 102, 25–37.
Hynnekleiv, L., Magno, M., Vernhardsdottir, R.R., Moschowits, E., Tønseth, K.A., Dartt, D.A. et al. (2022) Hyaluronic acid in the treatment of dry eye disease. Acta Ophthalmologica, 100, 844–860.
Iester, M., Orsoni, G.J., Gamba, G., Taffara, M., Mangiafico, P., Giuffrida, S. et al. (2000) Improvement of the ocular surface using hypotonic 0.4% hyaluronic acid drops in keratoconjunctivitis sicca. Eye (London, England), 14, 892–898.
Jones, L., Downie, L.E., Korb, D., Benitez‐del‐Castillo, J.M., Dana, R., Deng, S.X. et al. (2017) TFOS DEWS II management and therapy report. The Ocular Surface, 15, 575–628.
Kaercher, T., Hönig, D. & Barth, W. (1999) How the most common preservative affects the Meibomian lipid layer. Orbit, 18, 89–97.
Kasetsuwan, N. & Reinprayoon, U. (2015) A sodium hyaluronate ophthalmic solution for reducing dry eye and enhancing corneal wound healing after photorefractive keratectomy (PRK). Asian Journal of Pharmaceutical and Clinical Research, 8, 226–231.
Katz, J.I., Kaufman, H.E., Breslin, C. & Katz, I.M. (1978) Slow‐release artificial tears and the treatment of keratitis sicca. Ophthalmology, 85, 787–793.
Khanal, S., Tomlinson, A., Pearce, E.I. & Simmons, P.A. (2007) Effect of an oil‐in‐water emulsion on the tear physiology of patients with mild to moderate dry eye. Cornea, 26, 175–181.
Kheirkhah, A., Kobashi, H., Girgis, J., Jamali, A., Ciolino, J.B. & Hamrah, P. (2020) A randomized, sham‐controlled trial of intraductal meibomian gland probing with or without topical antibiotic/steroid for obstructive meibomian gland dysfunction. The Ocular Surface, 18, 852–856.
Koroloff, N., Boots, R., Lipman, J., Thomas, P., Rickard, C. & Coyer, F. (2004) A randomised controlled study of the efficacy of hypromellose and Lacri‐lube combination versus polyethylene/cling wrap to prevent corneal epithelial breakdown in the semiconscious intensive care patient. Intensive Care Medicine, 30, 1122–1126.
Lensen, S. (2023) When to pool data in a meta‐analysis (and when not to)? Fertility and Sterility, 119, 902–903.
Lozano, J.S., Chay, E.Y., Healey, J., Sullenberger, R. & Klarlund, J.K. (2008) Activation of the epidermal growth factor receptor by hydrogels in artificial tears. Experimental Eye Research, 86, 500–505.
Maharana, P.K., Raghuwanshi, S., Chauhan, A.K., Rai, V.G. & Pattebahadur, R. (2017) Comparison of the efficacy of carboxymethylcellulose 0.5%, hydroxypropyl‐guar containing polyethylene glycol 400/propylene glycol, and hydroxypropyl methyl cellulose 0.3% tear substitutes in improving ocular surface disease index in cases of dry eye. Middle East African Journal of Ophthalmology, 24, 202–206.
Marner, K. & Prause, J.U. (1984) A comparative clinical study of tear substitutes in normal subjects and in patients with keratoconjunctivitis sicca. Acta Ophthalmologica, 62, 91–95.
McCann, L.C., Tomlinson, A., Pearce, E.I. & Papa, V. (2012) Effectiveness of artificial tears in the management of evaporative dry eye. Cornea, 31, 1–5.
McDonald, M., Patel, D.A., Keith, M.S. & Snedecor, S.J. (2016) Economic and humanistic burden of dry eye disease in Europe, North America, and Asia: a systematic literature review. The Ocular Surface, 14, 144–167.
McGinnigle, S., Eperjesi, F. & Naroo, S.A. (2014) A preliminary investigation into the effects of ocular lubricants on higher order aberrations in normal and dry eye subjects. Contact Lens & Anterior Eye, 37, 106–110.
McMonnies, C.W. (2020) Aqueous deficiency is a contributor to evaporation‐related dry eye disease. Eye and Vision, 7, 6.
Messmer, E.M. (2015) The pathophysiology, diagnosis, and treatment of dry eye disease. Deutsches Ärzteblatt International, 112, 71–82.
Moshirfar, M., Pierson, K., Hanamaikai, K., Santiago‐Caban, L., Muthappan, V. & Passi, S.F. (2014) Artificial tears potpourri: a literature review. Clinical Ophthalmology, 8, 1419–1433.
Moss, S.E., Klein, R. & Klein, B.E.K. (2004) Incidence of dry eye in an older population. Archives of Ophthalmology, 122, 369–373.
Motolko, M. & Breslin, C.W. (1981) The effect of pH and osmolarity on the ability of tolerate artificial tears. American Journal of Ophthalmology, 91, 781–784.
Nelson, J.D., Drake, M.M., Brewer, J.T., Jr. & Tuley, M. (1994) Evaluation of a physiological tear substitute in patients with keratoconjunctivitis sicca. Advances in Experimental Medicine and Biology, 350, 453–457.
Novack, G.D., Asbell, P., Barabino, S., Bergamini, M.V.W., Ciolino, J.B., Foulks, G.N. et al. (2017) TFOS DEWS II clinical trial design report. The Ocular Surface, 15, 629–649.
Paugh, J.R., Nguyen, A.L., Ketelson, H.A., Christensen, M.T. & Meadows, D.L. (2008) Precorneal residence time of artificial tears measured in dry eye subjects. Optometry and Vision Science, 85, 725–731.
Peng, W.‐y., R‐x Chen, H., Dai, L.Z., Li, Y., Gao, Z.‐q., Li, X.‐y. et al. (2021) Efficacy, safety, and tolerability of a novel cyclosporine, a formulation for dry eye disease: A multicenter phase I clinical study. Clinical Therapeutics, 43, 613–628.
Prabhasawat, P., Tesavibul, N. & Kasetsuwan, N. (2007) Performance profile of sodium hyaluronate in patients with lipid tear deficiency: randomised, double‐blind, controlled, exploratory study. The British Journal of Ophthalmology, 91, 47–50.
Pucker, A.D., Ng, S.M. & Nichols, J.J. (2016) Over the counter (OTC) artificial tear drops for dry eye syndrome. Cochrane Database of Systematic Reviews, 2016, CD009729.
Raber, I. & Breslin, C.W. (1978) Toleration of artificial tears—The effect of pH. Canadian Journal of Ophthalmology, 13, 247–249.
Rajendraprasad, R.M., Kwatra, G. & Batra, N. (2021) Carboxymethyl cellulose versus hydroxypropyl methylcellulose tear substitutes for dry eye due to computer vision syndrome: comparison of efficacy and safety. International Journal of Applied & Basic Medical Research, 11, 4–8.
Reddy, M., Reddy, P. & Reddy, S. (1991) Conjunctival impression cytology in dry eye states. Indian Journal of Ophthalmology, 39, 22–24.
Roszkowska, A.M., Spinella, R., Oliverio, G.W., Postorino, E.I., Signorino, G.A., Rusciano, D. et al. (2022) Effects of the topical use of the natural antioxidant alpha‐Lipoic acid on the ocular surface of diabetic patients with dry eye symptoms. FBL, 27, 202.
Safarzadeh, M., Azizzadeh, P. & Akbarshahi, P. (2017) Comparison of the clinical efficacy of preserved and preservative‐free hydroxypropyl methylcellulose‐dextran‐containing eyedrops. Journal of Optometry, 10, 258–264.
Schaumberg, D.A., Sullivan, D.A., Buring, J.E. & Dana, M.R. (2003) Prevalence of dry eye syndrome among US women. American Journal of Ophthalmology, 136, 318–326.
Siepmann, J. & Peppas, N.A. (2012) Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Advanced Drug Delivery Reviews, 64, 163–174.
Simmons, P.A. & Vehige, J.G. (2007) Clinical performance of a mid‐viscosity artificial tear for dry eye treatment. Cornea, 26, 294–302.
Smith, G.T., Lee, S. & Taylor, H.R. (1993) Open evaluation of a new non‐preserved artificial tear. Australian and New Zealand Journal of Ophthalmology, 21, 105–109.
Snibson, G.R., Greaves, J.L., Soper, N.D., Tiffany, J.M., Wilson, C.G. & Bron, A.J. (1992) Ocular surface residence times of artificial tear solutions. Cornea, 11, 288–293.
Stapleton, F., Alves, M., Bunya, V.Y., Jalbert, I., Lekhanont, K., Malet, F. et al. (2017) TFOS DEWS II epidemiology report. The Ocular Surface, 15, 334–365.
Stern, M.E., Gao, J., Siemasko, K.F., Beuerman, R.W. & Pflugfelder, S.C. (2004) The role of the lacrimal functional unit in the pathophysiology of dry eye. Experimental Eye Research, 78, 409–416.
Taiti, L., Scrivanti, M., Mencucci, R., Bardi, L. & Salvi, G. (1993) A double‐masked crossover comparison of a new artificial tear preparation containing hyaluronic acid (L02A) and a reference artificial tear preparation containing hydroxypropyl‐methylcellulose in dry‐eye syndrome treatment. Annali di Ottalmologia e Clinica Oculistica, 119, 33–46.
Tauber, J. (2007) Efficacy, tolerability and comfort of a 0.3% hypromellose gel ophthalmic lubricant in the treatment of patients with moderate to severe dry eye syndrome. Current Medical Research and Opinion, 23, 2629–2636.
Tsubota, K., Pflugfelder, S.C., Liu, Z., Baudouin, C., Kim, H.M., Messmer, E.M. et al. (2020) Defining dry eye from a clinical perspective. International Journal of Molecular Sciences, 21, 9271.
Ubels, J.L., Williams, K.K., Lopez Bernal, D. & Edelhauser, H.F. (1994) Evaluation of effects of a physiologic artificial tear on the corneal epithelial barrier: electrical resistance and carboxyfluorescein permeability. Advances in Experimental Medicine and Biology, 350, 441–452.
Vassiliadi, E., Mitsou, E., Avramiotis, S., Chochos, C.L., Pirolt, F., Medebach, M. et al. (2020) Structural study of (Hydroxypropyl)methyl cellulose microemulsion‐based gels used for biocompatible encapsulations. Nanomaterials (Basel), 10, 2204.
Velpandian, T. & Moksha, L. (2016) Mucoadhesive polymers and ocular lubricants. In: Velpandian, T. (Ed.) Pharmacology of ocular therapeutics. Switzerland: Cham. Springer International Publishing, pp. 269–283.
Versura, P., Maltarello, M.C., Stecher, F., Caramazza, R. & Laschi, R. (1989) Dry eye before and after therapy with hydroxypropyl methylcellulose. Ultrastructural and cytochemical study in 20 patients. Ophthalmologica, 198, 152–162.
Walt, J., Rowe, M. & Stern, K. (1997) Evaluating the functional impact of dry eye: the ocular surface disease index. Drug Information Journal, 31, b5.
Wegener, A.R., Meyer, L.M. & Schönfeld, C.L. (2015) Effect of viscous agents on corneal density in dry eye disease. Journal of Ocular Pharmacology and Therapeutics, 31, 504–508.
White, C.J., Thomas, C.R. & Byrne, M.E. (2014) Bringing comfort to the masses: a novel evaluation of comfort agent solution properties. Contact Lens & Anterior Eye, 37, 81–91.
Willcox, M.D.P., Argüeso, P., Georgiev, G.A., Holopainen, J.M., Laurie, G.W., Millar, T.J. et al. (2017) TFOS DEWS II tear film report. The Ocular Surface, 15, 366–403.
Wolffsohn, J.S., Arita, R., Chalmers, R., Djalilian, A., Dogru, M., Dumbleton, K. et al. (2017) TFOS DEWS II diagnostic methodology report. The Ocular Surface, 15, 539–574.
Wright, P., Cooper, M. & Gilvarry, A.M. (1987) Effect of osmolarity of artificial tear drops on relief of dry eye symptoms: BJ6 and beyond. The British Journal of Ophthalmology, 71, 161–164.
Yamaguchi, T. (2018) Inflammatory response in dry eye. Investigative Ophthalmology & Visual Science, 59, DES192–DES199.
Yang, Y.J., Lee, W.Y., Kim, Y.J. & Hong, Y.P. (2021) A meta‐analysis of the efficacy of hyaluronic acid eye drops for the treatment of dry eye syndrome. International Journal of Environmental Research and Public Health, 18, 2383. https://doi.org/10.3390/ijerph18052383
Yu, J., Asche, C.V. & Fairchild, C.J. (2011) The economic burden of dry eye disease in the United States: a decision tree analysis. Cornea, 30, 379–387.
Zhou, X.Q. & Wei, R.L. (2014) Topical cyclosporine a in the treatment of dry eye: a systematic review and meta‐analysis. Cornea, 33, 760–767.